史密斯與尼普洛 INTELLIO 平板
K 號：K221929 · 2022-09-06
廣告
器材摘要
Smith+Nephew INTELLIO Tablet is the device name listed in this FDA 510(k) record. The listed applicant is Smith+Nephew. It received FDA 510(k) clearance on 2022-09-06 under 510(k) number K221929. The device is classified under product code ODA. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
常見問題
What is the Smith+Nephew INTELLIO Tablet?
Smith+Nephew INTELLIO Tablet is a medical device that received FDA 510(k) clearance on 2022-09-06. The listed applicant is Smith+Nephew. The 510(k) number is K221929.
When did Smith+Nephew INTELLIO Tablet receive FDA 510(k) clearance?
Smith+Nephew INTELLIO Tablet received FDA 510(k) clearance on 2022-09-06, under 510(k) number K221929.
Who is the listed applicant for Smith+Nephew INTELLIO Tablet?
The FDA 510(k) record lists Smith+Nephew as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Smith+Nephew INTELLIO Tablet?
The FDA product code for Smith+Nephew INTELLIO Tablet is ODA.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
相關器械（代碼：ODA）
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告